You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

Ofatumumab

Showing 26 - 50 of 163
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Chronic Lymphocytic Leukemia Trial in Houston (Ofatumumab)

Active, not recruiting
  • Chronic Lymphocytic Leukemia
  • Ofatumumab
  • Houston, Texas
    University of Texas MD Anderson Cancer Center
Feb 23, 2022

Relapse Remitting Multiple Sclerosis Trial in United States (Ofatumumab)

Recruiting
  • Relapse Remitting Multiple Sclerosis
  • Ofatumumab
  • Chandler, Arizona
  • +16 more
Jan 13, 2023

The 'Wearing Off' Effect of DMT

Recruiting
  • Multiple Sclerosis
  • ocrelizumab
  • +2 more
  • Basel, Switzerland
    Novartis Investigative Site
Jan 24, 2023

Chronic Lymphocytic Leukemia Trial in Spain (Ibrutinib 140 MG Oral Capsule [Imbruvica])

Active, not recruiting
  • Chronic Lymphocytic Leukemia
  • Ibrutinib 140 MG Oral Capsule [Imbruvica]
  • Palma De Mallorca, Illes Balears, Spain
  • +19 more
Sep 15, 2022

Chronic Lymphocytic Leukemia Trial in Spain (Ofatumumab)

Completed
  • Chronic Lymphocytic Leukemia
  • Ofatumumab
  • Badalona, Spain
  • +8 more
May 2, 2022

Diffuse Large Cell Lymphoma Relapsed/Refractory Trial in San Francisco (Ofatumumab, Etoposide, Cytarabine)

Completed
Has Results
  • Diffuse Large Cell Lymphoma Relapsed/Refractory
  • Ofatumumab
  • +2 more
  • San Francisco, California
    University of California, San Francisco
Jun 5, 2022

Czech Pharmaco-epidemiological Study on Disease Modifying Drugs

Completed
  • Multiple Sclerosis
  • interferons, glatiramer acetate, teriflunomide, dimethyl fumarate, alemtuzumab, cladribine, fingolimod, ponesimod, rituximab, ocrelizumab, ofatumumab, natalizumab
  • Prague, Czechia
    IMPULS Endowment Fund
Mar 7, 2023

Mantle Cell Lymphoma Trial in United States (Ofatumumab (This arm is closed), Ofatumumab + Bendamustine)

Active, not recruiting
  • Mantle Cell Lymphoma
  • Ofatumumab (This arm is closed)
  • Ofatumumab + Bendamustine
  • Basking Ridge, New Jersey
  • +5 more
Oct 1, 2021

Chronic Lymphocytic Leukemia Trial in Houston (Ofatumumab)

Completed
Has Results
  • Chronic Lymphocytic Leukemia
  • Ofatumumab
  • Houston, Texas
    M D Anderson Cancer Center
Jul 22, 2021

Relapsing Multiple Sclerosis Trial in United States (Quadrivalent influenza vaccine, Ofatumumab)

Recruiting
  • Relapsing Multiple Sclerosis
  • Quadrivalent influenza vaccine
  • Ofatumumab
  • Phoenix, Arizona
  • +3 more
Aug 30, 2021

Relapsing Multiple Sclerosis Trial in Puerto Rico, United States (Ofatumumab)

Recruiting
  • Relapsing Multiple Sclerosis
  • Ofatumumab
  • Birmingham, Alabama
  • +16 more
Mar 22, 2022

Relapsing Multiple Sclerosis Trial in Boston (Ofatumumab, [F-18]PBR06)

Recruiting
  • Relapsing Multiple Sclerosis
  • Boston, Massachusetts
    Partners MS Center, 60 Fenwood Road
Jul 20, 2021

Multiple Sclerosis (MS) Trial in Worldwide (Fingolimod, Ofatumumab, Siponimod)

Recruiting
  • Multiple Sclerosis (MS)
  • Little Rock, Arkansas
  • +55 more
Jan 13, 2023

Chronic Lymphocytic Leukemia, Small Lymphocytic Lymphoma Trial in Tampa (High Dose Methylprednisolone (HDMP), Ofatumumab,

Completed
Has Results
  • Chronic Lymphocytic Leukemia
  • Small Lymphocytic Lymphoma
  • High Dose Methylprednisolone (HDMP)
  • +2 more
  • Tampa, Florida
    H. Lee Moffitt Cancer Center and Research Institute
Apr 2, 2021

Kesimpta® Treatment Effects in Relapsing Multiple Sclerosis

Recruiting
  • Multiple Sclerosis
  • Ofatumumab
  • Bamberg, Bavaria, Germany
  • +21 more
Jan 25, 2023

Diffuse Large B Cell Lymphoma Trial in Poland (Ofatumumab, Etoposide, Ifosfamid)

Completed
  • Diffuse Large B Cell Lymphoma
  • Ofatumumab
  • +7 more
  • Wrocław, Dolnośląskie, Poland
  • +7 more
Dec 23, 2021

Stage I Mantle Cell Lymphoma, Stage II Contiguous Mantle Cell Lymphoma, Stage II Non-Contiguous Mantle Cell Lymphoma Trial in

Active, not recruiting
Has Results
  • Stage I Mantle Cell Lymphoma
  • +4 more
  • Autologous Hematopoietic Stem Cell Transplantation
  • +8 more
  • Buffalo, New York
  • +1 more
Mar 9, 2022

Chronic Lymphocytic Leukemia Trial in Sacramento (Ofatumumab + Fresh Frozen Plasma)

Completed
Has Results
  • Chronic Lymphocytic Leukemia
  • Ofatumumab + Fresh Frozen Plasma
  • Sacramento, California
    University of California Comprehensive Cancer Center
Apr 17, 2021

Multiple Sclerosis Trial in Worldwide (Ofatumumab, First line DMT)

Recruiting
  • Multiple Sclerosis
  • Ofatumumab
  • First line DMT
  • Bayonne, Bayonne Cedex, France
  • +42 more
Jul 25, 2022

Multiple Sclerosis, Healthy Trial in Philadelphia (thoracic duct cannulation)

Not yet recruiting
  • Multiple Sclerosis
  • Healthy
  • thoracic duct cannulation
  • Philadelphia, Pennsylvania
    University of Pennsylvania
Dec 6, 2021

Multiple Sclerosis Trial in Worldwide (ofatumumab with PRF, ofatumumab with AI)

Completed
Has Results
  • Multiple Sclerosis
  • ofatumumab with PRF
  • ofatumumab with AI
  • Fullerton, California
  • +40 more
Oct 7, 2021

Follicular Lymphoma, Grade 1, Follicular Lymphoma, Grade 2, Follicular Lymphoma Grade 3A Trial in Italy (OFATUMUMAB)

Completed
  • Follicular Lymphoma, Grade 1
  • +2 more
  • OFATUMUMAB
  • Alessandria, AL, Italy
  • +26 more
Jun 16, 2022

Stage I Chronic Lymphocytic Leukemia, Stage II Chronic Lymphocytic Leukemia, Stage III Chronic Lymphocytic Leukemia Trial in

Active, not recruiting
Has Results
  • Stage I Chronic Lymphocytic Leukemia
  • +3 more
  • alemtuzumab
  • +2 more
  • Chicago, Illinois
  • +1 more
Dec 29, 2020

s in Patients With Relapsing Multiple Sclerosis

Recruiting
  • Relapsing Multiple Sclerosis
  • ofatumumab
  • +2 more
  • Untermeiting, Bayern, Germany
  • +35 more
Aug 12, 2022

Chronic Lymphocytic Leukemia, Small Lymphocytic Lymphoma Trial in Worldwide (Duvelisib, Ofatumumab)

Completed
Has Results
  • Chronic Lymphocytic Leukemia
  • Small Lymphocytic Lymphoma
  • La Jolla, California
  • +91 more
Dec 14, 2021